Search results for: 'test the'

This study carries Frost & Sullivan’s observation of bone mineral density solutions in select Asian Countries (Australia, South Korea, and China); the regulatory trends for the same have been covered, highlighting the following: • Product registration and regulatory approval process details in select Asian countries (such as the Therapeutic Goods A...

This research service analyses the IVD market in Taiwan strategically by evaluating the various forces that are currently influencing this market. It analyzes the revenue potential for the key segments in this market, namely clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular testing, SMBG, and point-of-care testing, a...

Waste to Energy projects for disposal of MSW are a relatively new concept in India. Although these have been tried and tested in developed countries with positive results, these are yet to prove their success in India largely because of the fact that financial and commercial viability is still being tested. Municipal Solid Waste (MSW) contains orga...

The market for healthcare services in Malaysia is less developed, with many clinical testing services being unavailable outside of cities. Unsubstantiated disease and unconfirmed mortality diagnoses are common in the country despite universal care, significant mixed investment in the local healthcare system, and health expenditure favourable to oth...

The electric vehicle charging infrastructure in South Korea is expected to grow considerably, encouraged by government funding and incentives but high costs of installation and new technology weaken the value proposition. Moreover, the business models of hardware manufacturers and service providers have not yet been defined, as the EV market is in ...

Healthcare expenditure in Singapore is expected to grow, fueled by factors such as rising incomes and a progressively aging population. Diagnostics has emerged as a way for earlier and better identification of diseases to control rising healthcare costs in Singapore. Hence, the country has become a natural choice for many global diagnostic companie...

The APAC chromatography market is estimated to experience a CAGR of approximately 2.5% from 2019 to 2025, reaching $1,618.6 million. The objective of this study is to identify the key trends prevailing in the market in the base year 2019 and what factors boost and restrain market growth. In particular, it also discusses the product areas, vertical...

The In-vitro Diagnostics (IVD) market in China shows strong growth potential in several segments. Market growth is set to be driven by the growing volume of tests, rather than the higher price of testing solutions in traditional segments and the popularization of advanced testing technology in emerging segments. In the context of the reform in publ...

This research service analyses the IVD in Korea, strategically, by evaluating the various forces that are currently shaping this market. It analyses the revenue potential for the key segments in this market, namely, clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, SMBG and point-of-care testing and fore...